Edition:
India

People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

77.91USD
1:30am IST
Change (% chg)

$0.58 (+0.75%)
Prev Close
$77.33
Open
$77.68
Day's High
$78.65
Day's Low
$77.00
Volume
542,119
Avg. Vol
727,262
52-wk High
$131.86
52-wk Low
$67.18

Mueller, Brian 

Mr. Brian R. Mueller CPA serves as Chief Financial Officer, Executive Vice President of the Company. He joined BioMarin in December 2002 and currently serves as the Company’s Senior Vice President, Finance and Chief Accounting Officer in addition to his role as acting Chief Financial Officer. He has served as BioMarin’s Chief Accounting Officer since March 2011. From March 2014 to August 2016, Mr. Mueller served as the Company’s Group Vice President, Corporate Controller and from March 2009 to March 2014, Mr. Mueller served as the Company’s Vice President, Corporate Controller. Mr. Mueller is a member of the board of Directors of Anthera Pharmaceuticals, Inc., a biopharmaceutical company where he also served as Chairman of the Audit Committee. Prior to joining BioMarin in 2002, Mr. Mueller worked for KPMG as a senior manager in the firm’s audit practice. Mr. Mueller joined KPMG after Arthur Andersen LLP ceased operations in June 2002, prior to which he spent seven years with Arthur Andersen LLP in the firm’s audit and business advisory services practice. Mr. Mueller received a B.S. in Accountancy from Northern Illinois University in DeKalb, Illinois, and is a member of the American Institute of Certified Public Accountants.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jean-Jacques Bienaime

18,405,900

Brian Mueller

--

Henry Fuchs

7,017,500

C. Greg Guyer

--

G. Eric Davis

2,708,210

Jeff Ajer

6,344,320
As Of  31 Dec 2019